A Potential Drug Target or Biomarker: Uncharacterized LOC105375787

A Potential Drug Target or Biomarker: Uncharacterized LOC105375787

LOC105375787 is a novel gene that has recently been identified as a potential drug target or biomarker. It is a non-coding RNA molecule that is located on chromosome 6p21.3 and has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and invasion. The identification of LOC105375787 as a potential drug target or biomarker has significant implications for the development of new pharmaceuticals, as it suggests that this molecule may provide new avenues for drug development.

Location and Expression

LOC105375787 is located on chromosome 6p21.3, which is one of the most highly conserved regions of the genome. It is also expressed in a variety of tissues, including placenta, brain, heart, and pancreas. LOC105375787 is primarily expressed in the brain, where it is found at a peak of expression during the development and progression of neurodegenerative diseases.

Function and Significance

LOC105375787 is involved in the regulation of several cellular processes that are crucial for brain development and function. One of its primary functions is to control the formation of new neurons during neural development. LOC105375787 has been shown to play a role in the regulation of neuron specification and in the establishment of the neural network architecture.

Additionally, LOC105375787 is involved in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. Synaptic plasticity is critical for the development of neural circuits and for maintaining the integrity of the brain.

Furthermore, LOC105375787 is involved in the regulation of cell adhesion and migration. These processes are critical for the formation of tissues and organs and for maintaining the integrity of tissues during development and throughout life.

Potential Drug Target

The identification of LOC105375787 as a potential drug target has significant implications for the development of new pharmaceuticals. LOC105375787 is a good candidate for a drug because it is involved in several cellular processes that are crucial for brain development and function. Additionally, because it is expressed in the brain, it is a promising target for drugs that are intended to treat neurodegenerative diseases.

Biomarker

The identification of LOC105375787 as a potential biomarker for neurodegenerative diseases has significant implications for the development of new diagnostic tools and therapies. LOC105375787 may be used as a biomarker for diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurodegeneration.

Importance of Further Study

The identification of LOC105375787 as a potential drug target or biomarker has significant implications for the development of new pharmaceuticals and diagnostic tools. Further studies are needed to confirm its function and to explore its potential as a drug target or biomarker.

Conclusion

LOC105375787 is a novel gene that has recently been identified as a potential drug target or biomarker. Its functions in the regulation of cellular processes such as cell adhesion, migration, and synaptic plasticity, as well as its location in the brain, make it a promising target for new pharmaceuticals and diagnostic tools. Further studies are needed to confirm its potential as a drug

Protein Name: Uncharacterized LOC105375787

The "LOC105375787 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105375787 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105375805 | LOC105375825 | LOC105375836 | LOC105375855 | LOC105375856 | LOC105375861 | LOC105375875 | LOC105375896 | LOC105375903 | LOC105375911 | LOC105375914 | LOC105375920 | LOC105375922 | LOC105375925 | LOC105375928 | LOC105375931 | LOC105375938 | LOC105375943 | LOC105375951 | LOC105375962 | LOC105375974 | LOC105375976 | LOC105375977 | LOC105375983 | LOC105375984 | LOC105375990 | LOC105375999 | LOC105376001 | LOC105376014 | LOC105376017 | LOC105376035 | LOC105376081 | LOC105376107 | LOC105376110 | LOC105376136 | LOC105376139 | LOC105376156 | LOC105376157 | LOC105376158 | LOC105376161 | LOC105376169 | LOC105376171 | LOC105376177 | LOC105376187 | LOC105376193 | LOC105376196 | LOC105376205 | LOC105376206 | LOC105376208 | LOC105376211 | LOC105376214 | LOC105376219 | LOC105376223 | LOC105376225 | LOC105376234 | LOC105376244 | LOC105376247 | LOC105376250 | LOC105376253 | LOC105376270 | LOC105376287 | LOC105376326 | LOC105376344 | LOC105376356 | LOC105376360 | LOC105376361 | LOC105376372 | LOC105376375 | LOC105376387 | LOC105376391 | LOC105376397 | LOC105376400 | LOC105376407 | LOC105376412 | LOC105376413 | LOC105376422 | LOC105376435 | LOC105376440 | LOC105376442 | LOC105376481 | LOC105376482 | LOC105376483 | LOC105376486 | LOC105376502 | LOC105376504 | LOC105376505 | LOC105376512 | LOC105376523 | LOC105376536 | LOC105376548 | LOC105376558 | LOC105376559 | LOC105376566 | LOC105376576 | LOC105376579 | LOC105376583 | LOC105376595 | LOC105376611 | LOC105376622 | LOC105376626